Skip to content
  • Facebook
  • Twitter
  • Instagram
  • Email

ORCHESTRA Cohort

A Horizon 2020 cohort

  • Project
  • Community
  • Contact

Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study

A.Savoldi, M.Morra, P. D. Nardo, A. M. Cattelan, M. Mirandola et al.

Contributing partner:

University of Verona (UNIVR)

Scientific article available at:

European Journal of Clinical Microbiology & Infectious Diseases

Published 21/06/2022By aleksandr.belonozhkin
Categorized as publication

ORCHESTRA has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 101016167.

Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic
EU Call: H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
Start date: 1 December 2020   End date: 30 November 2024
Coordinated by: UNIVERSITA DEGLI STUDI DI VERONA

© 2024 Orchestra. All right reserved.   Privacy Policy   Imprint